A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
Safety and tolerability study of 2 concentrations of QLS-101 for adult subjects with Sturge
Weber Syndrome (SWS)-related glaucoma due to elevated episcleral venous pressure (EVP).